Wacker Chemie AG header image

Wacker Chemie AG

WCH

Equity

ISIN DE000WCH8881 / Valor 2493384

Xetra (2026-05-29)
EUR 99.30-0.10%

Wacker Chemie AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Wacker Chemie AG is a global chemical company headquartered in Munich, Germany, known for its diverse portfolio in the chemical industry. The company operates in several key segments, including silicones, polymers, biosolutions, and polysilicon. In the biosolutions sector, Wacker Chemie AG serves as a full-service contract manufacturer, specializing in the production of plasmid DNA (pDNA), messenger ribonucleic acid (mRNA) including lipid nanoparticles (LNPs), therapeutic proteins, live biotherapeutic products (LBPs), and vaccines utilizing microbial systems. This focus on biotechnological applications highlights Wacker's commitment to advancing healthcare and life sciences through innovative chemical solutions. The company's extensive expertise and capabilities in these areas position it as a significant player in the global chemical and biotechnology markets.

Summarized from source with an LLMView SourceSector: Industrials

Latest Results (18.05.2026):

Wacker Chemie AG — Q1 2026: Sales were €1,406m (-5% y/y) while EBITDA rose to €173m (+45% y/y), driven by the PACE cost program and pull‑forward order effects; EBIT turned positive to €52m and net income was €15m. Liquidity stood at €1.44bn and net financial debt was €964m. Management raised the FY 2026 sales outlook (to high‑single‑digit % growth) while keeping EBITDA guidance unchanged at €550–700m.

Key financials (Q1 2026)

Sales €1,406m (-5% y/y); EBITDA €173m (+45% y/y) with a 12.3% margin; EBIT €52m (vs. -€7m in Q1/25); Net income €15m; EPS €0.21. CapEx €61m; net cash flow -€32m (improved vs -€165m); net financial debt €964m.

What drove results

EBITDA uplift came primarily from the PACE cost‑reduction program and pull‑forward demand (notably from effects related to the Middle East crisis). FX weighed on sales (~-4%); pricing was slightly negative in the quarter (-1%); volumes/mix roughly flat. Price increases in Silicones and Polymers were announced late March to address rising input costs.

Segment performance (Q1 2026)

Silicones: sales €708m, EBITDA €117m (16.5% margin). Polymers: €333m / €50m (14.9%). Biosolutions: €100m / €13m (13.5%). Polysilicon: €226m / €23m (10.0%). Others: loss €27m. Group consolidation effects minor.

Balance sheet & liquidity

High liquidity at €1.44bn and shareholders’ equity €3.82bn (equity ratio ~45%). Net financial debt moved to €964m (from €886m at year‑end), reflecting operating and investing cash flows, dividend/lease outflows and FX effects. Reported financial liabilities ~€2.40bn.

Outlook for FY 2026

Sales guidance was raised to high‑single‑digit percentage growth y/y (updated); EBITDA guidance remains unchanged at €550–700m. Guidance excludes potential impacts from changes in polysilicon trade policies. Management indicates FY CapEx approximately €300m (guidance range).

Cost‑savings program (PACE)

PACE is a central driver: management targets >€300m in savings by 2028 and cites PACE as a key contributor to the Q1 EBITDA improvement.

Operational highlights & market context

Wacker commissioned a new production line in Japan for thermally conductive silicones to serve e‑mobility/battery customers. Semiconductor demand was strong (supporting polysilicon volumes); solar demand remains weak/uncertain. Order intake showed pull‑forward effects and volatility related to geopolitical developments.

Summarized from source with an LLMView Source

Key figures

57.5%1Y
-23.5%3Y
-28.5%5Y

Performance

42.5%1Y
39.5%3Y
40.1%5Y

Volatility

Market cap

5753 M

Market cap (USD)

Daily traded volume (Shares)

154,920

Daily traded volume (Shares)

1 day high/low

70.72 / 69.34

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Balchem Corp
Balchem Corp Balchem Corp Valor: 910930
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.20%USD 156.73
Aumann AG
Aumann AG Aumann AG Valor: 36030369
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.36%EUR 13.85
STO SE & Co. KGaA
STO SE & Co. KGaA STO SE & Co. KGaA Valor: 348930
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.95%EUR 104.60
Cavco Industries Inc
Cavco Industries Inc Cavco Industries Inc Valor: 1597401
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%USD 536.52
Rocket Lab USA Inc
Rocket Lab USA Inc Rocket Lab USA Inc Valor: 112870399
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.07%USD 143.48
Weir Group PLC (The)
Weir Group PLC (The) Weir Group PLC (The) Valor: 94339
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.74%GBP 24.46
Vesuvius PLC
Vesuvius PLC Vesuvius PLC Valor: 19956890
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.35%GBP 4.64
Aurora Innovation Inc
Aurora Innovation Inc Aurora Innovation Inc Valor: 112781240
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.82%USD 7.34
Godrej Properties Limited
Godrej Properties Limited Godrej Properties Limited Valor: 22860505
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.39%INR 1,764.30
GMR Airports Ltd
GMR Airports Ltd GMR Airports Ltd Valor: 10663522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.67%INR 100.46